DTC Prescription Drug Advertising: The History and Impact of FDA Regulation

DSpace/Manakin Repository

DTC Prescription Drug Advertising: The History and Impact of FDA Regulation

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Hartgraves, Tiffany en_US
dc.date.accessioned 2012-06-07T20:11:39Z
dc.date.issued 2002 en_US
dc.identifier.citation DTC Prescription Drug Advertising: The History and Impact of FDA Regulation (2002 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852117
dc.description.abstract This paper traces the history of direct-to-consumer (DTC) advertising for prescription drugs in the United States, beginning with the enactment of the Federal Food, Drug, and Cosmetics Act in 1938 and continuing through the current state of FDA regulation. A detailed analysis of how the promulgation of DTC ads has affected a variety of groups (including consumers, the medical profession, pharmaceutical companies, the government, and advertisers) is followed by a brief look at a well-known DTC ad campaign (Schering-Plough’s Claritin). The paper questions whether DTC ads are a constructive or a deconstructive element of the American healthcare system and concludes by offering an opinion on the current state of DTC advertising regulation and enforcement by the FDA. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject DTC en
dc.subject advertising en
dc.subject policy en
dc.subject drugs en
dc.title DTC Prescription Drug Advertising: The History and Impact of FDA Regulation en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T20:11:39Z

Files in this item

Files Size Format View
hartgraves.pdf 453.1Kb PDF View/Open
hartgraves.rtf 789.5Kb RTF file View/Open
hartgraves.html 214.3Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters